Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Plasma antioxidant enzyme imbalance in childhood- and adolescent-onset schizophrenia: clinical correlates and diagnostic utility. Local targets link to admitted publications; unresolved targets remain external evidence.
Is adolescent-onset first-episode psychosis different from adult onset?
10.1097/01.chi.0000164591.55942.ea · 2005 · External reference
Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia
10.1016/j.neuron.2014.07.028 · 2014 · External reference
Global Epidemiology and burden of Schizophrenia: findings from the Global Burden of Disease Study 2016
10.1093/schbul/sby058 · 2018 · External reference
A systematic review of the long-term outcome of early onset schizophrenia
10.1186/1471-244x-12-150 · 2012 · External reference
Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
10.1016/j.euroneuro.2024.02.005 · 2024 · External reference
Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia
10.1038/s41380-021-01374-w · 2022 · External reference
Redox and immune signaling in schizophrenia: new therapeutic potential
10.1093/ijnp/pyad012 · 2023 · External reference
Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives
10.1155/2021/8881770 · 2021 · External reference
An optimized version of the positive and negative symptoms scale (PANSS) for pediatric trials
10.1016/j.jaac.2022.07.864 · 2023 · External reference
Mitochondrial dysfunction, altered Mitochondrial oxygen, and energy metabolism associated with the pathogenesis of schizophrenia
10.3390/ijms24097991 · 2023 · External reference
Meta-analysis of oxidative stress in schizophrenia
10.1016/j.biopsych.2013.03.018 · 2013 · External reference
Oxidative stress and inflammation in first-episode psychosis: a systematic review and meta-analysis
10.1093/schbul/sby125 · 2019 · External reference
Oxidative stress and inflammation in early onset first episode psychosis: a systematic review and meta-analysis
10.1093/ijnp/pyx015 · 2017 · External reference
Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia
10.1016/s0920-9964(02)00405-x · 2003 · External reference
Total antioxidant capacity, obesity and clinical correlates in first-episode and drug-naïve patients with schizophrenia
10.1016/j.schres.2023.12.004 · 2024 · External reference
Evaluation of inflammatory and oxidative markers and their diagnostic value in schizophrenia
10.3390/brainsci15111137 · 2025 · External reference
Interrelationships between depressive symptoms and positive and negative symptoms of recent onset schizophrenia spectrum disorders: a network analytical approach
10.1016/j.jpsychires.2021.05.038 · 2021 · External reference
Abnormal plasma oxidative stress markers in first-episode schizophrenia and associations with clinical symptoms and cognitive function
2026 · External reference
Association of oxidative stress-induced nucleic acid damage with psychiatric disorders in adults: a systematic review and meta-analysis
10.1001/jamapsychiatry.2022.2066 · 2022 · External reference
Natural compounds for oxidative stress and neuroprotection in schizophrenia: composition, mechanisms, and therapeutic potential
10.1080/1028415x.2024.2325233 · 2024 · External reference
Peroxiredoxin II preserves cognitive function against age-linked hippocampal oxidative damage
10.1016/j.neurobiolaging.2009.05.017 · 2011 · External reference
Age of onset moderates the association between total antioxidant capacity and cognitive deficits in patients with drug-naïve schizophrenia
10.3390/antiox12061259 · 2023 · External reference
Differential impacts of endogenous antioxidants on clinical symptoms and cognitive function in acute and chronic schizophrenia patients
10.1093/ijnp/pyad040 · 2023 · External reference
Oxidative stress and emergence of psychosis
10.3390/antiox11101870 · 2022 · External reference
Investigating the repeatable battery for the assessment of neuropsychological status (RBANS) executive errors scale in adults with schizophrenia spectrum disorders
10.1093/arclin/acaf104 · 2026 · External reference
Examining the repeatable battery for the assessment of neuropsychological status validity indices in people with schizophrenia spectrum disorders
10.1080/13854046.2021.1876169 · 2023 · External reference
Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: a 12-months follow-up study
10.1016/j.psychres.2012.07.024 · 2012 · External reference
Oxidative stress in children and adolescents: insights into Human biology
10.1002/ajhb.24200 · 2025 · External reference
Developmental changes in cerebral NAD and neuroenergetics of an antioxidant compromised mouse model of schizophrenia
10.1038/s41398-023-02568-2 · 2023 · External reference
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
10.1038/s41380-021-01161-7 · 2022 · External reference
Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia
10.1038/mp.2017.47 · 2017 · External reference
Immune and oxidative stress biomarkers in pediatric psychosis and psychosis-risk: meta-analyses and systematic review
10.1016/j.bbi.2023.12.019 · 2024 · External reference
Oxidative stress-mediated neuroinflammation in the pathophysiology of schizophrenia
10.3390/ijms262211139 · 2025 · External reference
Sex differences in the association between symptoms and superoxide dismutase in patients with never-treated first-episode schizophrenia
10.1080/15622975.2020.1805510 · 2021 · External reference
Association between MnSOD activity and cognitive impairment in unmedicated first-episode schizophrenia: regulated by MnSOD Ala-9Val gene polymorphism
2022 · External reference
Global, regional, and national burden of mental disorders among adolescents and young adults, 1990–2021: a systematic analysis for the global burden of disease study 2021
10.1038/s41398-025-03623-w · 2025 · External reference
Oxidative stress biomarkers among Schizophrenia inpatients
10.3390/brainsci13030490 · 2023 · External reference
Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients
10.1016/j.ajp.2022.103400 · 2023 · External reference
Cognitive impairment in adolescent and adult-onset psychosis: a comparative study
10.1186/s13034-024-00815-y · 2024 · External reference
Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia
10.1186/s12974-021-02261-5 · 2021 · External reference
